Jan 12 |
Notice of Deficiency with Nasdaq Continued Listing Requirements
|
Dec 4 |
10 Best Debt Free Penny Stocks To Buy Now
|
Dec 1 |
NLS Pharmaceutics Announces Exclusive Option Agreement to Develop and Commercialize Next Generation Dual Orexin Agonist Platform of Aexon Labs, Inc.
|
Nov 28 |
NLS Pharmaceutics Announces Election of Additional Board Members
|
Nov 27 |
NLS Pharmaceutics to Participate in the Oppenheimer Sleep Disorders Summit: Deep Dive into Narcolepsy and Idiopathic Hypersomnia
|
Nov 16 |
Why NLS Pharmaceutics (NLSP) Stock Is Down 40% Today
|
Nov 16 |
NLS Pharmaceutics Announces Selection of Strategic Partner and Securing a Bridge Loan
|